Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,480.00
0.00 (0.00%)
At close: Sep 11, 2026

Korea Arlico Pharm Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
18,46419,31215,48419,06623,3959,520
Short-Term Investments
1,00097.42652.726,1646,51213,612
Trading Asset Securities
3,5791,5843,0575,5602,2965,616
Cash & Short-Term Investments
23,04320,99319,19430,79032,20328,747
Cash Growth
35.27%9.37%-37.66%-4.39%12.02%47.30%
Accounts Receivable
24,43627,69330,07322,36219,88619,304
Other Receivables
231.96399.8650.1246.58110.4674.88
Receivables
24,66828,09330,12322,40919,99719,379
Inventory
31,85232,63732,79826,77927,43719,759
Prepaid Expenses
-4.637.057.977.255.78
Other Current Assets
2,0321,1753,2123,5702,479964.07
Total Current Assets
81,59582,90285,33483,55582,12368,855
Property, Plant & Equipment
60,33761,99463,15266,74049,72631,641
Long-Term Investments
8,4758,1968,73010,1379,31312,168
Other Intangible Assets
8,8628,6327,1487,0136,9583,967
Long-Term Accounts Receivable
----000
Long-Term Deferred Tax Assets
8,2607,3416,1404,3654,0713,741
Other Long-Term Assets
2,1391,778859.021,6661,344688.89
Total Assets
170,668171,844172,363173,477153,536121,062

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
7,2366,2717,3254,8514,8065,111
Accrued Expenses
9,4139,49010,69911,86812,40710,038
Short-Term Debt
36,69241,10441,53739,33025,06410,262
Current Portion of Long-Term Debt
2,6672,6671,932-2,000191.4
Current Portion of Leases
193.79245.65250.58152.42151.3582.2
Current Income Taxes Payable
524.89593.97--883.22840.4
Current Unearned Revenue
----2.46-
Other Current Liabilities
22,26813,59513,45214,11911,9447,244
Total Current Liabilities
78,99473,96675,19570,32057,25833,770
Long-Term Debt
3,6114,9446,5926,7463,7462,000
Long-Term Leases
53.8283.56145.6561.2135.0565.21
Pension & Post-Retirement Benefits
-0785.44610.34--727.58
Other Long-Term Liabilities
12,14413,86210,1407,2753,8513,370
Total Liabilities
94,80393,64192,68484,40264,99039,933

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
7,6647,6647,6647,6647,6647,664
Additional Paid-In Capital
40,47340,47340,14340,14340,14340,143
Retained Earnings
31,89734,23535,52043,74343,15635,904
Treasury Stock
-3,082-3,082-3,082-3,082-3,082-3,082
Comprehensive Income & Other
-1,086-1,086-565.06608.09665.54501.14
Shareholders' Equity
75,86578,20379,67989,07588,54681,129
Total Liabilities & Equity
170,668171,844172,363173,477153,536121,062

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
43,21749,04450,45746,28931,09612,601
Net Cash (Debt)
-20,174-28,051-31,263-15,4991,10716,146
Net Cash Growth
-----93.14%64.53%
Net Cash Per Share
-1347.99-1868.42-2082.99-526.6273.291071.03
Filing Date Shares Outstanding
15.0815.0115.0115.0115.0115.01
Total Common Shares Outstanding
15.0815.0115.0115.0115.0115.01
Working Capital
2,6018,93710,13913,23524,86535,085
Book Value Per Share
5031.665208.905307.225933.045897.815403.78
Tangible Book Value
67,00369,57172,53182,06281,58877,162
Tangible Book Value Per Share
4443.914633.924831.125465.905434.345139.54
Land
-21,86710,88411,40610,1889,607
Buildings
-24,59525,04630,18112,82415,655
Machinery
-12,69515,33431,5278,82215,961
Construction In Progress
-909.959,76710,78416,4181,608